USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer
In summary, USP18 shows great promise for research and clinical application as a potential target for CRC immunotherapy.
Authors
- Peijun Wang (ORCID: https://orcid.org/0000-0002-1034-9148)
- Jiaxin Ding
- Cili Jifu
- Jingtao Wang (ORCID: https://orcid.org/0009-0005-6235-9881)
- Meng‐Yao Lv
- Jun Xia
- Linxia Lü
Institutions
- Jiamusi University (CN)
Publication Details
- Journal
- Biomolecules
- Published
- 2024-09-21
- DOI
- https://doi.org/10.3390/biom14091191
- Citations
- 8
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 1.87
Funders
- National Natural Science Foundation of China